Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07302672

Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma

The goal of this clinical trial is to test whether human-centered nursing care lowers emotional distress and improves quality of life for people who are awake during thyroid thermal ablation. The procedure uses local anesthesia, so participants remain awake and may feel tense. Human-centered care focuses on emotional support, clear communication, comfort, and follow-up, and it may improve the experience and recovery for patients.

The main questions are:

Does human-centered nursing care reduce emotional distress levels in patients undergoing thyroid thermal ablation?

Does human-centered nursing care improve patient quality of life after thyroid thermal ablation?

If there is a comparison group: Researchers will compare human-centered nursing care to usual nursing care to see if human-centered care leads to lower emotional distress and higher quality of life.

Participants will:

Receive either human-centered nursing care or usual nursing care.

Complete questionnaires before, during, and after the procedure to measure emotional distress, quality of life, pain, and satisfaction with care.

Have their vital signs and quality of life tracked during and after the procedure.

Have their adherence to care plans and any complications monitored.

The main outcomes are emotional distress levels and quality of life. Other outcomes include pain and vital signs during the procedure, satisfaction with care, and complication rates. Results may guide better care for people undergoing small, minimally invasive treatments while awake.

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 16-60 years; scheduled for thyroid thermal ablation
  • Papillary thyroid carcinoma (PTC)
  • Number of target lesions <= 3
  • Largest lesion diameter <= 2 cm; clinical stage T1N0M0 by imaging
  • Awake and able to cooperate under local anesthesia

Owns a smartphone and can use WeChat

Exclusion criteria

  • Serious medical comorbidities or cognitive impairment that precludes participation
  • Prior thyroid surgery or thermal ablation
  • Unwilling or unable to join the WeChat group or complete postoperative follow-up

Treatment and study plan

Humanistic Continuing Care via WeChat

Behavioral

Description: Structured, humanistic peri-operative nursing program delivered through WeChat in addition to routine care. Components: pre-procedure needs assessment and expectation setting; brief coping skills coaching (e.g., paced breathing); intra-procedure step-by-step explanations, reassurance, and comfort measures; post-procedure education, recovery guidance, and psychosocial support; symptom monitoring with red-flag escalation; medication/wound-care and appointment reminders; on-demand messaging during service hours; optional caregiver engagement.

Delivery & Schedule: Nurse-led. One pre-procedure session; intra-procedure support on the day of ablation; post-procedure WeChat check-ins at least weekly plus on-demand messaging for 12 weeks. Fidelity tracked via standardized checklists.

Arm(s): Experimental - Humanistic Continuing Care via WeChat.

Usual Care (No Structured WeChat Program)

Procedure

Participants receive standard peri-operative nursing and institutional discharge materials, including routine pre-procedure counseling, standard intra-procedure monitoring, printed/posted instructions for home care, and follow-up per usual practice (e.g., clinic visit or routine phone call). They may contact the clinic using standard channels as needed, but there is no scheduled, structured WeChat outreach or humanistic continuing-care protocol.

Primary outcomes

  1. Change in emotion distress from baseline to post-procedure (HADS)

    Time frame: From enrollment to the end of treatment at 3 months

  2. Change in the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scores from baseline to 3 months

    Time frame: From enrollment to the end of treatment at 3 months

  3. Change in Thyroid Cancer-Specific Quality of Life Questionnaire scores from baseline to 3 months

    Time frame: From enrollment to 3 months after end of treatment

Secondary outcomes

  1. Intraoperative pain intensity (Visual Analog Scale)

    Time frame: Intraoperative period (during the procedure)

    Pain intensity during the procedure will be assessed using a Visual Analog Scale (VAS; 0-100 mm, where 0 indicates no pain and 10 indicates the worst imaginable pain). A single VAS score will be recorded during the intraoperative period.

  2. Patient satisfaction with nursing care (Newcastle Satisfaction with Nursing Scale, NSNS)

    Time frame: Postoperative Day 1

Study contacts

Contact information is provided by the study sponsor or research team.

ming-an yu, MD

CONTACT

[email protected]

84205756

Sponsors and collaborators

Lead sponsor

Ming-an Yu

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Dec 24, 2025
Registry last updated
Jul 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.